This Article Full Text Full Text (PDF) All Versions of this Article: 114/25/2823    most recent CIRCULATIONAHA.106.628623v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aicher, A. Articles by Dimmeler, S. Search for Related Content PubMed PubMed Citation Articles by Aicher, A. Articles by Dimmeler, S. Pubmed/NCBI databases Medline Plus Health Information Stem Cells Related Collections Angiogenesis Other Vascular biology

(Circulation. 2006;114:2823-2830.)
© 2006 American Heart Association, Inc.

Molecular Cardiology

Low-Energy Shock Wave for Enhancing Recruitment of Endothelial Progenitor Cells

A New Modality to Increase Efficacy of Cell Therapy in Chronic Hind Limb Ischemia

Alexandra Aicher, MD^*; Christopher Heeschen, MD^*; Ken-ichiro Sasaki, MD; Carmen Urbich, PhD; Andreas M. Zeiher, MD; Stefanie Dimmeler, PhD

From the Department of Internal Medicine III, J.W. Goethe University, 60590 Frankfurt, Germany.

Correspondence to Stefanie Dimmeler, PhD, Department of Medicine III, University of Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany. E-mail dimmeler{at}em.uni-frankfurt.de

Received March 21, 2006; revision received October 5, 2006; accepted October 11, 2006.

Background— Stem and progenitor cell therapy is a novel approach to improve neovascularization and function of ischemic tissue. Enhanced tissue expression of chemoattractant factors such as stromal cell–derived factor 1 and vascular endothelial growth factor is crucial for the recruitment of circulating endothelial progenitor cells (EPCs) during acute ischemia. In chronic ischemia, however, expression of these chemoattractants is less pronounced, which results in insufficient EPC recruitment into the target tissue. Therefore, we investigated the effect of targeted extracorporeal shock wave (SW) application in order to facilitate EPC recruitment into nonischemic and chronic ischemic tissue.

Methods and Results— Hind limb adductor muscles of nude rats were treated with 500, 1000, and 2000 impulses of focused low-energy SW (flux density level: 0.05 mJ/mm²). Twenty-four hours later, mRNA expression of the chemoattractant stromal cell–derived factor 1 was significantly increased with 1000 impulses (stromal cell–derived factor 1/GAPDH: 0.95±0.09) and 2000 impulses (stromal cell–derived factor 1/GAPDH: 1.17±0.24; both P<0.05 versus untreated). Histologically, the number of vascular endothelial growth factor–positive endothelial cells per myocyte was significantly increased with 2000 impulses (0.24±0.05 versus 0.09±0.02; P<0.01). This preconditioning effect resulted in significantly enhanced recruitment and homing of EPCs that were intravenously infused 24 hours after SW treatment (P<0.05). In a rat model of chronic hind limb ischemia, SW-facilitated EPC treatment resulted in a significant increase in relative blood flow recovery as assessed by laser Doppler imaging (P<0.05).

Conclusions— Preconditioning of both nonischemic and chronic ischemic tissue with low-energy SW improves recruitment of circulating EPCs via enhanced expression of chemoattractant factors. Thus, SW-facilitated cell therapy may improve the efficacy of EPC treatment in patients with chronic ischemia.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				V. Schachinger, A. Aicher, N. Dobert, R. Rover, J. Diener, S. Fichtlscherer, B. Assmus, F. H. Seeger, C. Menzel, W. Brenner, et al. Pilot Trial on Determinants of Progenitor Cell Recruitment to the Infarcted Human Myocardium Circulation, September 30, 2008; 118(14): 1425 - 1432. [Abstract] [Full Text] [PDF]

				S. Dimmeler and A. Leri Aging and Disease as Modifiers of Efficacy of Cell Therapy Circ. Res., June 6, 2008; 102(11): 1319 - 1330. [Abstract] [Full Text] [PDF]